XML 17 R2.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Oct. 31, 2024
Oct. 31, 2023
Oct. 31, 2024
Oct. 31, 2023
Income Statement [Abstract]        
Net sales $ 47,764 $ 50,436 $ 96,157 $ 100,275
Cost of products sold 33,812 36,968 69,717 74,893
Gross profit 13,952 13,468 26,440 25,382
Operating expenses 9,518 8,359 19,431 16,465
Operating profit 4,434 5,109 7,009 8,917
Pension expense 0 (40) 0 (81)
Other (expense) income, net (61) 148 266 223
Interest expense (442) (372) (914) (802)
Profit before income taxes 3,931 4,845 6,361 8,257
Income tax expense 916 2,015 1,108 2,912
Net earnings 3,015 2,830 5,253 5,345
Less: Net earnings attributable to the non-controlling interest 7 98 52 139
Net earnings attributable to Kewaunee Scientific Corporation $ 3,008 $ 2,732 $ 5,201 $ 5,206
Net earnings per share attributable to Kewaunee Scientific Corporation stockholders        
Basic (in dollars per share) $ 1.05 $ 0.94 $ 1.82 $ 1.81
Diluted (in dollars per share) $ 1.01 $ 0.93 $ 1.75 $ 1.79
Weighted average number of common shares outstanding        
Basic (in shares) 2,872 2,903 2,861 2,882
Diluted (in shares) 2,974 2,931 2,971 2,908